Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200529265> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4200529265 endingPage "816" @default.
- W4200529265 startingPage "807" @default.
- W4200529265 abstract "Zanubrutinib is an unfamiliar second generation selective Brutson's Tyrosine Kinase inhibitor used to treat mantle cell lymphoma. In the present analysis, a new, stability indicating reverse-phase, high performance liquid chromatography method was developed and validated for the determination of Zanubrutinib succeeding degradation studies as pert the International Conference on Harmonization guidelines. The chromatographic separation of Zanubrutinib was achieved in a C18 column (250 × 4.6 mm, 5-μm particle size) using a mobile phase of Acetonitrile: 0.1% Tri Ethyl Amine (65:35 v/v) monitored at 219 nm. The forced degradation studies were conducted by exposing the analyte to acidic, alkaline and neutral hydrolysis, oxidative, reductive, photolytic, and thermal stress conditions and the degradation behavior was studied. The analyte showed degradation under acidic, alkaline, oxidative and reductive stress conditions with additional peaks but, it was stable under neutral, photolytic and thermal stress conditions. The developed method was extended to triple quadruple mass spectrometry to characterize degradation products and to study the fragmentation pattern. Total four degradants were characterized including DP1 in acid &base hydrolysis, DP2 in oxidative and DP3, DP4 in reductive stress condition. As no substantial method was available for quantification of Zanubrutinib and to characterize zanubrutinib degradants, this method can be used for regular analysis in quality control labs." @default.
- W4200529265 created "2021-12-31" @default.
- W4200529265 creator A5010414367 @default.
- W4200529265 creator A5025478511 @default.
- W4200529265 creator A5026591692 @default.
- W4200529265 creator A5060030429 @default.
- W4200529265 creator A5077787865 @default.
- W4200529265 creator A5090852890 @default.
- W4200529265 date "2021-12-22" @default.
- W4200529265 modified "2023-10-06" @default.
- W4200529265 title "Forced Degradation Study of Zanubrutinib: An LC–PDA and LC–MS Approach" @default.
- W4200529265 cites W1910349555 @default.
- W4200529265 cites W1979816280 @default.
- W4200529265 cites W2014064833 @default.
- W4200529265 cites W2032482627 @default.
- W4200529265 cites W2064862416 @default.
- W4200529265 cites W2146029333 @default.
- W4200529265 cites W2154945466 @default.
- W4200529265 cites W2884194601 @default.
- W4200529265 cites W2972482801 @default.
- W4200529265 cites W2998982556 @default.
- W4200529265 doi "https://doi.org/10.1093/chromsci/bmab137" @default.
- W4200529265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34933329" @default.
- W4200529265 hasPublicationYear "2021" @default.
- W4200529265 type Work @default.
- W4200529265 citedByCount "2" @default.
- W4200529265 countsByYear W42005292652023 @default.
- W4200529265 crossrefType "journal-article" @default.
- W4200529265 hasAuthorship W4200529265A5010414367 @default.
- W4200529265 hasAuthorship W4200529265A5025478511 @default.
- W4200529265 hasAuthorship W4200529265A5026591692 @default.
- W4200529265 hasAuthorship W4200529265A5060030429 @default.
- W4200529265 hasAuthorship W4200529265A5077787865 @default.
- W4200529265 hasAuthorship W4200529265A5090852890 @default.
- W4200529265 hasConcept C162356407 @default.
- W4200529265 hasConcept C178790620 @default.
- W4200529265 hasConcept C179998833 @default.
- W4200529265 hasConcept C185592680 @default.
- W4200529265 hasConcept C2777463227 @default.
- W4200529265 hasConcept C2777682752 @default.
- W4200529265 hasConcept C2779679103 @default.
- W4200529265 hasConcept C41008148 @default.
- W4200529265 hasConcept C43617362 @default.
- W4200529265 hasConcept C45188465 @default.
- W4200529265 hasConcept C64489805 @default.
- W4200529265 hasConcept C76155785 @default.
- W4200529265 hasConcept C90932021 @default.
- W4200529265 hasConcept C94412978 @default.
- W4200529265 hasConceptScore W4200529265C162356407 @default.
- W4200529265 hasConceptScore W4200529265C178790620 @default.
- W4200529265 hasConceptScore W4200529265C179998833 @default.
- W4200529265 hasConceptScore W4200529265C185592680 @default.
- W4200529265 hasConceptScore W4200529265C2777463227 @default.
- W4200529265 hasConceptScore W4200529265C2777682752 @default.
- W4200529265 hasConceptScore W4200529265C2779679103 @default.
- W4200529265 hasConceptScore W4200529265C41008148 @default.
- W4200529265 hasConceptScore W4200529265C43617362 @default.
- W4200529265 hasConceptScore W4200529265C45188465 @default.
- W4200529265 hasConceptScore W4200529265C64489805 @default.
- W4200529265 hasConceptScore W4200529265C76155785 @default.
- W4200529265 hasConceptScore W4200529265C90932021 @default.
- W4200529265 hasConceptScore W4200529265C94412978 @default.
- W4200529265 hasIssue "9" @default.
- W4200529265 hasLocation W42005292651 @default.
- W4200529265 hasLocation W42005292652 @default.
- W4200529265 hasOpenAccess W4200529265 @default.
- W4200529265 hasPrimaryLocation W42005292651 @default.
- W4200529265 hasRelatedWork W2001720702 @default.
- W4200529265 hasRelatedWork W2034188269 @default.
- W4200529265 hasRelatedWork W2072764909 @default.
- W4200529265 hasRelatedWork W2087046738 @default.
- W4200529265 hasRelatedWork W2089660391 @default.
- W4200529265 hasRelatedWork W2132460047 @default.
- W4200529265 hasRelatedWork W2401221720 @default.
- W4200529265 hasRelatedWork W2403182174 @default.
- W4200529265 hasRelatedWork W2762211497 @default.
- W4200529265 hasRelatedWork W4385782945 @default.
- W4200529265 hasVolume "60" @default.
- W4200529265 isParatext "false" @default.
- W4200529265 isRetracted "false" @default.
- W4200529265 workType "article" @default.